Analysis of Immune Response Testing market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Immune response of the body depends on how it recognizes and protects itself against viruses, bacteria, and substances that are harmful. Advanced diagnostic laboratories use variety of technologies to determine the presence and absence of cell-mediated and antibody-mediated immune response to drugs, toxins, vaccines and pathogens.
Immune response testing measures the response of the immune system to vaccines. Various test are used to diagnose the immune response in individuals. Blood test determines the immune response level in blood and measure the level of blood cells and immune system cells.
Blood test also determines whether the immune system is responding properly and producing antibodies. The immune response testing in laboratories is done with the help of artificial antibodies, which exactly match the substance or germ. Immune response testing contains specific antibodies that bind the substance.
The major factors driving the growth of the market for immune response testing are increasing prevalence of immune-acquired diseases, such as HIV infections. Rising geriatric population and increasing healthcare expenditure are the other factors expected to drive the growth of the market for immune response testing.
Increasing number of research and development activities by the key players is also expected to spur the growth of the market for immune response testing over the forecast period. Likewise, increasing use of immunosuppressant drugs is expected to boost the growth of the immune response testing market.
However, lack of awareness regarding immune response diseases is expected to restrain the growth of the immune response testing market.
The global market for immune response testing is expected to register significant growth over the forecast period due to increasing prevalence of immune response diseases, such as HIV and rheumatoid arthritis. On the basis of test type, Elisa tests segment is expected to dominate the immune response testing market, owing to increasing demand for Elisa testing, its accuracy and specificity.
The rapid test segment is expected to witness high growth during the forecast period owing to its increasing usage, less time for diagnosis and cost effectiveness as compared to other tests. Increasing number of point-of-care testing centers across the globe is expected to fuel the growth of the market for immune response testing over forecast period.
Geographically, the global immune response testing market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the leading regional market for immune response testing owing to increasing advancement in the testing and increasing prevalence of immune response diseases.
The immune response testing market in Europe is expected to have second large share due improved infrastructure and use of handy POC diagnostic testing. The Asia Pacific excluding Japan is expected to witness fast growth than the other regions due to large patient population, increasing awareness and initiatives taken by the governments regarding immune response disease.
Japan is expected to account moderate growth in the immune response testing market owing to increasing geriatric population. Latin America and Middle East & Africa are expected to have slow growth over the forecast period.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
The global immune response testing market is highly fragmented owing to the presence of a large number of manufacturers. Examples of some of the key players operating in the global immune response testing market are
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Tentatively, the global immune response testing market can be segmented on the basis of test type, application, end user, and geography.
Based on test type, the global immune response testing market is segmented as:
Based on the application, the global immune response testing market is segmented as:
Based on end users, the global immune response testing market is segmented as:
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesPre Book
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Research Methodology -
An Adaptive Approach to Modern-day Research NeedsGet Methodology
The immune response testing market is expected to register a CAGR of 8% in the forecast period 2018-2028.
Abbott Laboratories, F. Hoffmann-La Roche Ltd, EUROIMMUN AG, Quest Diagnostics, Bio-Rad Laboratories Inc., Charles River, Creative Diagnostics are the key players in the immune response testing market?
North America is expected to possess 45% market share for immune response testing market in the forecast period 2018-2028.
The immune response testing market is worth US$ 63 billion in 2022.
Due to increasing use of immunosuppressant drugs, the immune response testing market expands at a CAGR of 11% by 2032.
Increasing healthcare expenditure provides fresh opportunities in the immune response testing market.
Need An Exclusive Report For Your Unique Requirement?